Get started
BASILEA PHARMACEUTICA AG ALLSCHWILBASILEA PHARMACEUTICA AG ALLSCHWILBASILEA PHARMACEUTICA AG ALLSCHWIL

BASILEA PHARMACEUTICA AG ALLSCHWIL

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

BPMUF chart

Upcoming earnings

Next report date
Report period
H1 2024
EPS estimate
1.03USD
Revenue estimate
‪93.90 M‬USD

Key stats

Market capitalization
‪529.69 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
70.24
Basic EPS (TTM)
1.04USD
Net income (FY)
‪12.41 M‬USD
Revenue (FY)
‪187.23 M‬USD
Shares float
‪11.00 M‬
Beta (1Y)
0.60

About BASILEA N

Sector
Health Technology
CEO
David Veitch
Headquarters
Allschwil
Website
basilea.com
Employees (FY)
147
Founded
2000
ISIN
CH0011432447
FIGI
BBG000KPTJV4
Basilea Pharmaceutica AG engages in the development and commercialization of pharmaceutical products. Its products include antifungals and antibiotics. The company was founded on October 17, 2000, and is headquartered in Allschwil, Switzerland.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BPMUF is 44.45 USD — it has increased by 9.08% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange BASILEA PHARMACEUTICA AG ALLSCHWIL stocks are traded under the ticker BPMUF.
BASILEA PHARMACEUTICA AG ALLSCHWIL is going to release the next earnings report on Aug 13, 2024. Keep track of upcoming events with our Earnings Calendar.
BPMUF stock is 8.41% volatile and has beta coefficient of 0.60. Check out the list of the most volatile stocks — is BASILEA PHARMACEUTICA AG ALLSCHWIL there?
BPMUF earnings for the last quarter are 2.70 USD per share, whereas the estimation was 0.90 USD resulting in a 200.62% surprise. The estimated earnings for the next quarter are −2.38 USD per share. See more details about BASILEA PHARMACEUTICA AG ALLSCHWIL earnings.
BASILEA PHARMACEUTICA AG ALLSCHWIL revenue for the last quarter amounts to ‪94.81 M‬ USD despite the estimated figure of ‪72.29 M‬ USD. In the next quarter revenue is expected to reach ‪85.44 M‬ USD.
Yes, you can track BASILEA PHARMACEUTICA AG ALLSCHWIL financials in yearly and quarterly reports right on TradingView.
BPMUF net income for the last quarter is ‪−25.40 M‬ USD, while the quarter before that showed ‪35.56 M‬ USD of net income which accounts for −171.45% change. Track more BASILEA PHARMACEUTICA AG ALLSCHWIL financial stats to get the full picture.
Today BASILEA PHARMACEUTICA AG ALLSCHWIL has the market capitalization of ‪529.06 M‬, it has increased by 6.82% over the last week.
No, BPMUF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BPMUF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BASILEA PHARMACEUTICA AG ALLSCHWIL stock right from TradingView charts — choose your broker and connect to your account.
BPMUF reached its all-time high on Sep 26, 2007 with the price of 230.00 USD, and its all-time low was 33.80 USD and was reached on Dec 15, 2011.
See other stocks reaching their highest and lowest prices.
As of Apr 26, 2024, the company has 147.00 employees. See our rating of the largest employees — is BASILEA PHARMACEUTICA AG ALLSCHWIL on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BASILEA PHARMACEUTICA AG ALLSCHWIL technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BASILEA PHARMACEUTICA AG ALLSCHWIL stock shows the sell signal. See more of BASILEA PHARMACEUTICA AG ALLSCHWIL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on BASILEA PHARMACEUTICA AG ALLSCHWIL future price: according to them, BPMUF price has a max estimate of 104.01 USD and a min estimate of 57.54 USD. Read a more detailed BASILEA PHARMACEUTICA AG ALLSCHWIL forecast: see what analysts think of BASILEA PHARMACEUTICA AG ALLSCHWIL and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BASILEA PHARMACEUTICA AG ALLSCHWIL EBITDA is ‪26.94 M‬ USD, and current EBITDA margin is 14.39%. See more stats in BASILEA PHARMACEUTICA AG ALLSCHWIL financial statements.